Atlas Trials

A Study Assessing the Efficacy and Safety of DE-127 Ophthalmic Solution in Subjects With Mild or Moderate Myopia (APPLE)

Clinical trial NCT03329638 · COMPLETED

Trial details

NCT number
NCT03329638
Sponsor
Santen Pharmaceutical Co., Ltd.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Myopia
Start date
2017-10-27
Primary completion
2019-09-12
Enrollment
99

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.